High-Molecular-Weight Hyaluronan Is a Hippo Pathway Ligand Directing Cell Density-Dependent Growth Inhibition via PAR1b

Autor: Masanori Hatakeyama, Naoko Murata-Kamiya, Takuya Ooki, Weida Wu, Atsushi Takahashi-Kanemitsu
Rok vydání: 2018
Předmět:
Hyaluronoglucosaminidase
Mice
Nude

Cell Count
Triple Negative Breast Neoplasms
Protein Serine-Threonine Kinases
GPI-Linked Proteins
General Biochemistry
Genetics and Molecular Biology

Extracellular matrix
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Cell Line
Tumor

Cell density
Extracellular
Animals
Humans
Hippo Signaling Pathway
Hyaluronic Acid
Phosphorylation
Molecular Biology
030304 developmental biology
0303 health sciences
Hippo signaling pathway
Mice
Inbred BALB C

biology
Kinase
CD44
Epithelial Cells
Cell Biology
MAP Kinase Kinase Kinases
Cell biology
Extracellular Matrix
HEK293 Cells
Hyaluronan Receptors
chemistry
Hippo signaling
biology.protein
MCF-7 Cells
Heterografts
Female
Growth inhibition
Cell Adhesion Molecules
030217 neurology & neurosurgery
Developmental Biology
Signal Transduction
Zdroj: Developmental cell. 49(4)
ISSN: 1878-1551
Popis: Summary High-molecular-weight hyaluronan, a major component of the extracellular matrix, is anti-oncogenic, whereas low-molecular-weight hyaluronan is pro-oncogenic, though the mechanisms underlying the size-dependent opposite bioactivities of hyaluronan remain uncertain. We show here that treatment with high-molecular-weight hyaluronan stimulates tumor-suppressive Hippo signaling in breast epithelial cells. Mechanistically, clustering of the CD44 extracellular domain by high-molecular-weight hyaluronan leads to recruitment of the polarity-regulating kinase PAR1b by the CD44 intracellular domain, which results in disruption of the Hippo signaling-inhibitory PAR1b-MST complex. Once liberated from PAR1b, MST activates Hippo signaling. Conversely, low-molecular-weight hyaluronan, which is produced by hyaluronidase-mediated degradation of high-molecular-weight hyaluronan, inhibits Hippo signaling by competing with high-molecular-weight hyaluronan for CD44 binding. Triple-negative breast cancers with higher hyaluronidase-2 expression show poorer prognosis than those with lower hyaluronidase-2 expression. Consistently, decreased hyaluronidase-2 is associated with reduced tumorigenicity in a tumor xenograft model. Hence, perturbation of high-molecular-weight hyaluronan-mediated Hippo signaling activation contributes to cancer aggressiveness.
Databáze: OpenAIRE